Data for: Efficacy and long-term survival of advanced lung adenocarcinoma patients with uncommon EGFR mutations treated with 1st generation EGFR-TKIs compared with chemotherapy as first-line therapy
Main Author: | Wang, Huijuan |
---|---|
Format: | Dataset |
Terbitan: |
Mendeley
, 2019
|
Subjects: | |
Online Access: |
https:/data.mendeley.com/datasets/9g58y64x5d |
Daftar Isi:
- Supplemental figure. The effect of EGFR-TKIs in patients with uncommon EGFR mutations showed a similar PFS, but OS was lower than in advanced lung adenocarcinoma patients with common EGFR mutations.